Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH Article

Cairncross, J Gregory, Wang, Meihua, Jenkins, Robert B et al. (2014). Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH . JOURNAL OF CLINICAL ONCOLOGY, 32(8), 783-+. 10.1200/JCO.2013.49.3726

Open Access ESI Most Cited Paper International Collaboration

cited authors

  • Cairncross, J Gregory; Wang, Meihua; Jenkins, Robert B; Shaw, Edward G; Giannini, Caterina; Brachman, David G; Buckner, Jan C; Fink, Karen L; Souhami, Luis; Laperriere, Normand J; Huse, Jason T; Mehta, Minesh P; Curran, Walter J

sustainable development goals

authors

publication date

  • March 10, 2014

published in

keywords

  • ADJUVANT PROCARBAZINE
  • ANAPLASTIC OLIGODENDROGLIOMA
  • BRAIN-TUMORS
  • EUROPEAN-ORGANIZATION
  • FOLLOW-UP
  • Life Sciences & Biomedicine
  • MGMT GENE
  • Oncology
  • PHASE-III TRIAL
  • SUCCESSFUL CHEMOTHERAPY
  • SURVIVAL
  • Science & Technology
  • TEMOZOLOMIDE

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 783

end page

  • +

volume

  • 32

issue

  • 8